Skip to main navigation Skip to search Skip to main content

Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study

  • James Chih Hsin Yang
  • , Wu Chou Su
  • , Chao Hua Chiu
  • , Her Shyong Shiah
  • , Kang Yun Lee
  • , Te Chun Hsia
  • , Makiko Uno
  • , Nigel Crawford
  • , Hiroshi Terakawa
  • , Wen Chi Chen
  • , Gensuke Takayama
  • , Ching Hsu
  • , Ying Hong
  • , Carline Saintilien
  • , Joseph McGill
  • , Gee Chen Chang

Research output: Contribution to journal › Article › peer-review

8   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science